DZ3393A1 - METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY - Google Patents
METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITYInfo
- Publication number
- DZ3393A1 DZ3393A1 DZ013393A DZ013393A DZ3393A1 DZ 3393 A1 DZ3393 A1 DZ 3393A1 DZ 013393 A DZ013393 A DZ 013393A DZ 013393 A DZ013393 A DZ 013393A DZ 3393 A1 DZ3393 A1 DZ 3393A1
- Authority
- DZ
- Algeria
- Prior art keywords
- prophylaxis
- obesity
- detection
- treatment
- compounds suitable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10035227A DE10035227A1 (en) | 2000-07-20 | 2000-07-20 | Selection and use of lipogenesis inhibitors for the treatment and prevention of obesity |
PCT/EP2001/008051 WO2002007821A1 (en) | 2000-07-20 | 2001-07-12 | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3393A1 true DZ3393A1 (en) | 2002-01-31 |
Family
ID=7649538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ013393A DZ3393A1 (en) | 2000-07-20 | 2001-07-12 | METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1307262B1 (en) |
JP (1) | JP2004504053A (en) |
KR (1) | KR100818827B1 (en) |
CN (1) | CN1443085B (en) |
AR (1) | AR028730A1 (en) |
AT (1) | ATE278441T1 (en) |
AU (2) | AU7753401A (en) |
BR (1) | BR0112547A (en) |
CA (1) | CA2416647A1 (en) |
CZ (1) | CZ2003156A3 (en) |
DE (2) | DE10035227A1 (en) |
DZ (1) | DZ3393A1 (en) |
ES (1) | ES2230346T3 (en) |
HK (1) | HK1057499A1 (en) |
HU (1) | HUP0302309A3 (en) |
IL (2) | IL153971A0 (en) |
MX (1) | MXPA02012907A (en) |
NO (1) | NO20030233L (en) |
NZ (1) | NZ523960A (en) |
PL (1) | PL201165B1 (en) |
PT (1) | PT1307262E (en) |
RU (1) | RU2268721C2 (en) |
SK (1) | SK287607B6 (en) |
TR (1) | TR200402670T4 (en) |
TW (1) | TWI274157B (en) |
UA (1) | UA74588C2 (en) |
WO (1) | WO2002007821A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007538054A (en) | 2004-05-19 | 2007-12-27 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Drug containing N-sulfamoyl-N'-arylpiperazine for the prevention or treatment of obesity and related diseases |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
CA2609185A1 (en) | 2005-05-20 | 2006-11-30 | Ahmed F. Abdel-Magid | Process for preparation of sulfamide derivatives |
TW200804393A (en) | 2005-11-14 | 2008-01-16 | Solvay Pharm Gmbh | Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
AR058389A1 (en) * | 2005-12-19 | 2008-01-30 | Janssen Pharmaceutica Nv | USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
EP2026790A2 (en) | 2006-05-19 | 2009-02-25 | Janssen Pharmaceutica, N.V. | Co-therapy for the treatment of epilepsy and related disorders |
NZ579229A (en) | 2007-01-25 | 2011-07-29 | Verva Pharmaceuticals Ltd | Insulin sensitisers and methods of treatment |
MX2011000090A (en) | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems. |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
BR112014029308A2 (en) * | 2012-05-24 | 2017-06-27 | Verva Pharmaceuticals Ltd | a method of improving liver function |
CN106770611B (en) * | 2016-12-22 | 2019-01-29 | 广西师范大学 | A method of entering mitochondria for cell in-situ detection small molecule compound |
RU2771430C1 (en) * | 2021-09-21 | 2022-05-04 | Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) | Method for the quantitative determination of anticonvulsants in the blood plasma of patients with epilepsy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552897A (en) * | 1983-02-01 | 1985-11-12 | American Cyanamid Company | Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom |
US6288095B1 (en) * | 1987-09-04 | 2001-09-11 | Beecham Group P.L.C. | Compounds |
US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
DE69305091T2 (en) * | 1992-10-29 | 1997-03-13 | Genentech Inc | METHOD FOR TREATING OR PREVENTING OBESITY |
AU693478B2 (en) * | 1994-11-10 | 1998-07-02 | Metabolic Pharmaceuticals Limited | Treatment of obesity |
ATE224189T1 (en) * | 1996-06-28 | 2002-10-15 | Ortho Mcneil Pharm Inc | ANTICONVULSIVE SULFAMATE DERIVATIVES FOR THE TREATMENT OF OBESITY |
US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
-
2000
- 2000-07-20 DE DE10035227A patent/DE10035227A1/en not_active Withdrawn
-
2001
- 2001-06-15 AR ARP010102883A patent/AR028730A1/en unknown
- 2001-07-12 TR TR2004/02670T patent/TR200402670T4/en unknown
- 2001-07-12 WO PCT/EP2001/008051 patent/WO2002007821A1/en active IP Right Grant
- 2001-07-12 EP EP01955345A patent/EP1307262B1/en not_active Expired - Lifetime
- 2001-07-12 PT PT01955345T patent/PT1307262E/en unknown
- 2001-07-12 JP JP2002513551A patent/JP2004504053A/en active Pending
- 2001-07-12 HU HU0302309A patent/HUP0302309A3/en unknown
- 2001-07-12 NZ NZ52396001A patent/NZ523960A/en not_active IP Right Cessation
- 2001-07-12 DE DE50104023T patent/DE50104023D1/en not_active Expired - Lifetime
- 2001-07-12 RU RU2003104803/14A patent/RU2268721C2/en not_active IP Right Cessation
- 2001-07-12 DZ DZ013393A patent/DZ3393A1/en active
- 2001-07-12 BR BR0112547-8A patent/BR0112547A/en not_active Application Discontinuation
- 2001-07-12 IL IL15397101A patent/IL153971A0/en unknown
- 2001-07-12 AU AU7753401A patent/AU7753401A/en active Pending
- 2001-07-12 CN CN018129730A patent/CN1443085B/en not_active Expired - Fee Related
- 2001-07-12 ES ES01955345T patent/ES2230346T3/en not_active Expired - Lifetime
- 2001-07-12 SK SK61-2003A patent/SK287607B6/en not_active IP Right Cessation
- 2001-07-12 AU AU2001277534A patent/AU2001277534B9/en not_active Ceased
- 2001-07-12 AT AT01955345T patent/ATE278441T1/en active
- 2001-07-12 KR KR1020037000620A patent/KR100818827B1/en not_active IP Right Cessation
- 2001-07-12 CZ CZ2003156A patent/CZ2003156A3/en unknown
- 2001-07-12 MX MXPA02012907A patent/MXPA02012907A/en active IP Right Grant
- 2001-07-12 CA CA002416647A patent/CA2416647A1/en not_active Abandoned
- 2001-07-12 PL PL363518A patent/PL201165B1/en not_active IP Right Cessation
- 2001-07-16 TW TW090117382A patent/TWI274157B/en not_active IP Right Cessation
- 2001-12-07 UA UA2003021453A patent/UA74588C2/en unknown
-
2003
- 2003-01-15 IL IL153971A patent/IL153971A/en not_active IP Right Cessation
- 2003-01-17 NO NO20030233A patent/NO20030233L/en unknown
-
2004
- 2004-01-15 HK HK04100307.4A patent/HK1057499A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ3393A1 (en) | METHOD FOR THE DETECTION OF COMPOUNDS SUITABLE FOR THE TREATMENT AND / OR PROPHYLAXIS OF OBESITY | |
FR2785521B1 (en) | SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES | |
FR2781168B1 (en) | WATER TREATMENT PROCESS AND INSTALLATION | |
FR07C0046I2 (en) | BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B | |
MA26889A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE CHRONIC AND / OR NEUROPATHIC PAIN AND MIGRAINES | |
CH1143977H1 (en) | 2-Oxy-benzoxazine-4-ones for the treatment of obesity | |
FR2733512B1 (en) | PROCESS FOR INHIBITING OR DELAYING THE FORMATION, GROWTH AND / OR AGGLOMERATION OF HYDRATES IN PRODUCTION EFFLUENTS | |
FR2830962B1 (en) | IMAGE PROCESSING DEVICE AND METHOD FOR DETECTION OF EVOLUTIVE LESIONS | |
FR2775078B1 (en) | METHOD AND DEVICE FOR THE TREATMENT OF DISHWASHER IN DISHWASHER | |
FR2816513B1 (en) | SUBCUTANEOUS VALVE FOR THE TREATMENT OF HYDROCEPHALIA AND ITS ADJUSTMENT DEVICES | |
DZ3014A1 (en) | Medicines for the treatment of hypertension. | |
FR2815541B1 (en) | USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY | |
FR2785898B1 (en) | PROCESS AND INSTALLATION FOR SANITATION OF BASIN WATERS SUCH AS POOL WATERS | |
FR2728142B1 (en) | COMPOSITION FOR THE ANTI-GERMINATING TREATMENT OF TUBERS OR BULBS; TREATMENT PROCESS | |
FR2795398B1 (en) | PROCESS AND PLANT FOR THE TREATMENT OF AGRICULTURAL EFFLUENTS | |
MA26592A1 (en) | METHOD AND MEDICAMENT USING CYCLIC COMPOUNDS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY | |
FR2710073B1 (en) | Apparatus allowing the reactivation and the programmed distribution of lyophilized bacteria for the treatment of effluents. | |
FR2724376B1 (en) | PROCESS OF IN SITU TREATMENT OF SEDIMENTS AND IN PARTICULAR VASES | |
FR2816611B1 (en) | WASTEWATER TREATMENT PROCESS | |
FR2752834B1 (en) | IMPROVED PROCESS FOR GIVING HYDROPHOBIC PROPERTIES TO THE SURFACES OF SILICAOUS ARTICLES | |
FR2800628B3 (en) | PROCESS FOR THE TREATMENT OF GASEOUS EFFLUENTS AND FUMES | |
FR2804861B1 (en) | ASSISTANCE DEVICE FOR THE ELDERLY OR DISABLED | |
FR2813808B1 (en) | PROCESS AND DEVICE FOR THE TREATMENT OF WASTE | |
FR2825696B1 (en) | MATERIAL AND METHOD FOR THE TREATMENT OF PHOTOGRAPHIC EFFLUENTS | |
FR2828189B1 (en) | PROCESS FOR TREATING EFFLUENTS FROM NON-COLLECTIVE SANITATION |